Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
O'Brien (Part B: recently infected asymptomatic patients), 2021 | randomized controlled trial |
O'Brien MP et al. medrxiv;2021.06.14.21258569v1 10.1101/2021.06.14.21258569 |
|||
CT-P59 1.2, 2020 | randomized controlled trial | no clinically relevant endpoint | preliminary unpublished results extracted from the EMA review document. < Study carried out before the release of the omicron variant > |